DIA Clinical & Regulatory Operational Excellence Forum, the latest in the Drug Information Association (DIA) series of events, will focus on how increasing complexities in today’s drug development require a close link between Clinical Operations and Regulatory Operations. The forum will help delegates to perform complex tasks to the highest operational standards to shorten turnaround times and reduce queries and re-creation in development programmes.
Romuald Braun, Vice President Strategy, Amplexor Life Sciences, a global provider in language services and regulatory, quality and safety software solutions, will be a co-presenter on the “Submission Planning and Control through a Product Lifecycle, Today and Tomorrow” workshop. Featuring alongside Braun, will be: Mark Cottingham, Senior Business Lead, F. Hoffmann-La Roche; and Tomaž Kobe, Head of Delivery Management, Amplexor, Life Sciences.
Join Amplexor Life Sciences at the upcoming DIA Clinical & Regulatory Operational Excellence Forum. The workshop on submission planning and control through a product lifecycle, seeks to trigger the audience’s minds into rethinking the automatisation of submission execution process, and understand how it can be further optimised, while increasing oversight and regulatory compliance.
13-14 September 2017. Workshop at 15:30 – 17:00 on 13 September, Room MOA7
Mercure Hotel MOA Berlin
Throughout the forum, Amplexor’s Regulatory and Language Service experts will be on hand to discuss your regulatory information management, data and multi-lingual content creation and management challenges and obtain insights and advice into how your data and content projects can be addressed.
To schedule a one-on-one discussion with an Amplexor Life Sciences regulatory management expert, email email@example.com.